Christina Elston

christina-elston-cedars-sinai

Supervisor, Science Communications 

Christina Elston covers the Department of Biomedical Sciences, Cedars-Sinai Cancer and the Board of Governors Regenerative Medicine Institute. Before joining the Cedars-Sinai Newsroom team in 2021, Christina was editor of L.A. Parent magazine, providing information on education, health and parenting to families across Los Angeles County. Her decades-long career in journalism also includes an Annenberg Health Journalism Fellowship and authorship of two books on children’s health and safety. Christina can be reached at [email protected].

 

 

 


Latest From This Author

September
04,
2026
| 06:00 AM America/Los_Angeles
Study Links Lower PSA Target to Better Prostate Cancer Survival

A new study led by Cedars-Sinai Health Sciences University investigators found that prostate-specific antigen (PSA) levels in the blood, which are used

August
31,
2026
| 02:00 AM America/Los_Angeles

When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences University

August
12,
2026
| 10:00 AM America/Los_Angeles
Mensajeros de las Células Cerebrales Arrojan Luz Sobre Parkinson

Las células cerebrales que liberan dopamina —una sustancia química mensajera que interviene en el control del movimiento— la almacenan en pequeños

August
07,
2026
| 06:00 AM America/Los_Angeles
Brain Cell Messengers Shed Light on Parkinson’s Disease

Brain cells that release dopamine—a messenger chemical that drives motor control— package it into tiny membrane-bound sacs called synaptic vesicles. And these

August
03,
2026
| 06:00 AM America/Los_Angeles

Cedars-Sinai Health Sciences University investigators have identified a protein that helps repair damage to the bone marrow after chemotherapy and radiation.

The protein restores the blood stem cell niche—the specialized environment that

July
30,
2026
| 08:00 AM America/Los_Angeles

Las mujeres que obtienen un resultado negativo para mutaciones en los genes BRCA aún pueden tener un mayor riesgo de desarrollar cáncer de mama que la población general, según un estudio dirigido por investigadores de Cedars-Sinai Health

July
30,
2026
| 08:00 AM America/Los_Angeles

Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by Cedars-Sinai Health Sciences University investigators. The findings, published in

July
14,
2026
| 08:00 AM America/Los_Angeles

Cedars-Sinai Cancer investigators have identified metabolites produced by gut bacteria that help the body’s immune system fight cancer. These chemicals, called indoles, are produced when the bacteria break down nutrients, and their

July
10,
2026
| 06:00 AM America/Los_Angeles
The Latest Advances From Cedars-Sinai Investigators

 Cedars-Sinai Study Links Hypertension to Socioeconomic Level

People living in under-resourced neighborhoods are more likely to develop high blood pressure—also